Phreesia, Inc. (PHR) Fair Value 2026

PHR · Health Information Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.4 /10

32 fundamental signals · 8 models active

Value Trap Risk

LOW (35/100)

Quick Summary — As of 2026-08-31, Phreesia, Inc. (PHR) trades at $12.21, versus a $10.46 median fair value across its 8 active models — 14.4% below the current price. QOC: 8.4/10. Value Trap Risk: 35/100 (LOW). 8/13 models active. Within that set, the Bayesian DCF component alone returns $17.13.

Key Facts

Ticker
PHR
Price
$12.21
Quality Score
8.4/10
Value Trap Risk
35/100
Models Active
8/13
Last Updated
Strength: Bayesian DCF suggests +40.3% upside with 73% confidence
Risk: Majority of models suggest overvaluation

Is Phreesia, Inc. (PHR) Undervalued or Overvalued in 2026?

According to CirclFi’s 8-model valuation engine, Phreesia, Inc. (PHR) appears overvalued as of : the median of 8 independent fair value estimates is $10.46, 14.4% below the current price of $12.21. Estimates range from $1.65 to $70.68. PHR scores 8.4/10 on fundamental quality and 35/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.1% versus its own 13-model consensus, across 3,804 rated companies as of 2026-08-31. PHR’s -14.4% gap is narrower than that market norm, and the Health Information Services sector median is -2.9%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Phreesia, Inc. Stock in 2026? →

What Fair Value Does Each Model Give PHR?

8 Intrinsic Value Models vs. Current Price ($12.21)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $17.13 +40.3%
Ensemble · Low Conviction
 $11.42 -6.4%
Scenario · High Conviction
 $9.49 -22.3%
Asset-Based · High Conviction
 $1.65 -86.5%
Unlock the Full Matrix

Access 4 additional models including Regime Cross-Sectional, Sentiment SOTP, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 8 Models →

Cancel anytime · No contracts · Instant access

What Is PHR's Fair Value Range?

Spread across 8 independent models · $1.65 to $70.68

CirclFi's 8 active models place Phreesia, Inc. (PHR) between $1.65 and $70.68 per share, a spread of 660% of the median. The median of that range — $10.46 — is the fair value CirclFi publishes for PHR, against a current price of $12.21.

Low · Dynamic NAVHigh · Regime Cross
$1.65median $10.46$70.68
Where the range comes from
Most bearish modelDynamic NAV$1.65
Most bullish modelRegime Cross-Sectional$70.68
Model agreement3 bullish · 5 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for PHR. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on PHR, not a CirclFi price target. How each model works →

What Is Phreesia, Inc. (PHR) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Phreesia, Inc.'s intrinsic value is estimated at a median fair value of $10.46. Trading at $12.21, the stock is approaching fair value or slight overvaluation (implied return of -14.4%), as 5 of 8 models suggest limited further upside. The most optimistic model, Regime Cross, places fair value at $70.68 (+478.9%), while Dynamic NAV — the most conservative — estimates $1.65 (-86.5%). This +565.4% gap reflects genuine analytical uncertainty about Phreesia, Inc.'s intrinsic worth. Among models with highest confidence, Bayesian DCF lean bullish — adding weight to the bullish side of the thesis.

What Do the Models Say About PHR?

8 of 13 models are currently active for PHR. Of these, 3 models suggest upside while 5 models suggest overvaluation. Taken together, their median fair value for PHR is $10.46 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $17.13 on its own, implying +40.3% upside from the current price. See which stocks rank higher →

How Does PHR Rank in Health Information Services?

Among 55 Health Information Services stocks, PHR ranks #7 by Quality of Company score. CirclFi's QOC score of 8.4/10 evaluates 32 fundamental signals. A score of 8.4 places PHR in the top tier.

See all Most Undervalued Health Information Services Stocks →

Phreesia, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is PHR a Value Trap?

CirclFi's Value Trap algorithm assigns PHR a score of 35/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

8 of 13 models are active for Phreesia, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Phreesia, Inc. scores 8.4 out of 10 on our 32-signal quality assessment, a strong rating that demonstrates strong fundamentals across the majority of our quality signals. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +565.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every PHR valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across PHR's 8 active models, average confidence is 48%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Phreesia, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Health Information Services Stocks Should You Also Analyze?

11 related Health Information Services stocks with 13-model coverage

VASOVaso CorporationQOC 8.5CCLDCareCloud, Inc.QOC 8.4SPOKSpok Holdings, Inc.QOC 8.6OPRXOptimizeRx CorporationQOC 8.3HSTMHealthStream, Inc.QOC 8.7GDRXGoodRx Holdings, Inc.QOC 8.1SDGRSchrödinger, Inc.QOC 7.1PBSVPharma-Bio Serv, Inc.QOC 5.9MSPRMSP Recovery, Inc.QOC 4.7DOCSDoximity, Inc.QOC 9.6HQYHealthEquity, Inc.QOC 9.5

Read investment analysis: VASO · CCLD · SPOK · OPRX · HSTM · GDRX · SDGR · PBSV · MSPR · DOCS · HQY

Which Other Stocks Have a Similar Quality Score to PHR?

7 companies across all industries closest to PHR’s Quality of Company score of 8.4/10.

FUNCFirst United CorporationQOC 8.4MPTIM-tron Industries, Inc.QOC 8.4HNRGHallador Energy CompanyQOC 8.4ROSTRoss Stores, Inc.QOC 8.4HSTHost Hotels & Resorts, Inc.QOC 8.4RRCRange Resources CorporationQOC 8.4NVDANVIDIA CorporationQOC 10.0

Read investment analysis: FUNC · MPTI · HNRG · ROST · HST · RRC · NVDA

Where Does PHR Sit in CirclFi's Health Information Services Rankings?

PHR is ranked against every other Health Information Services stock CirclFi covers in each of these screens.

See all Health Information Services stocks ranked →

What Else Do Investors Ask About Phreesia, Inc.’s Valuation?

What is Phreesia, Inc.'s intrinsic value in 2026?

CirclFi puts Phreesia, Inc. (PHR)'s intrinsic value at $10.46 — the median of 8 independent model estimates as of 2026-08-31, ranging from $1.65 to $70.68. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $17.13 on its own. The Quality of Company score is 8.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is PHR overvalued or undervalued right now?

At $12.21, 3 of 8 active models suggest PHR may be undervalued, while 5 indicate potential overvaluation. The median of all 8 fair value estimates is $10.46, 14.4% below the current price of $12.21 — a consensus view that PHR is overvalued. The assessment depends on which methodology best fits Phreesia, Inc.'s business model in Health Information Services.

What does a Quality of Company score of 8.4 mean for PHR?

Phreesia, Inc.'s QOC of 8.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on PHR?

CirclFi analyzes PHR with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 8 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on PHR?

Of the 8 models currently active on PHR, Regime Cross-Sectional is the most bullish at $70.68 per share, and Dynamic NAV is the most bearish at $1.65. CirclFi's published fair value for PHR is the median of that range, $10.46, not either extreme. The gap between the two ends equals 660% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is PHR a value trap in 2026?

Phreesia, Inc.'s Value Trap score is 35/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 8-model valuation engine, Phreesia, Inc. (PHR) has a median fair value of $10.46 — 14.4% below the current price of $12.21 — as of 2026-08-31.” Source: circlfi.com/stock/PHR/ · Methodology
Primary sources for this PHR valuation
  • Financial statements: Phreesia, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001412408) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for PHR as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 8 mathematical frameworks give you clarity on PHR.

Unlock All 8 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

4 models hidden for PHR Unlock All 8 — $39/mo